Medicare opens access to GLP-1 weight-loss drugs
Seeking Alpha ·
The Centers for Medicare & Medicaid Services on Wednesday launched a new program to offer GLP-1 weight-loss drugs to Medicare enrollees, benefiting millions of older Americans and further tightening Eli Lilly's ( LLY ) and Novo Nordisk’s ( NVO ) grip
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
469 participants
Related News
- Salesforce climbs after Guggenheim upgrades to Buy
- New Era Energy & Digital names Nelson as Chairman and CEO
- AVAX One Technology signs LOI to acquire Alberta AI data center site for $2.3M
- Enterprise Products Partners co-CEO Teague to retire in January
- Check Point Software rises after Guggenheim upgrades to Buy
- Microsoft Plans to Cut 5,500 Jobs in Latest Cost-Cutting Round